Journal of Nuclear Medicine November 2024, jnumed.124.268119; DOI: https://doi.org/10.2967/jnumed.124.268119 ...

Over the last 2 decades, significant progress has been made in our understanding of the genomics, tumor immune microenvironment, and immunogenicity of malignant melanoma. Historically, the prognosis ...

Journal of Nuclear Medicine November 2024, jnumed.124.268751; DOI: https://doi.org/10.2967/jnumed.124.268751 ...

Journal of Nuclear Medicine November 2024, jnumed.124.268807; DOI: https://doi.org/10.2967/jnumed.124.268807 ...

Journal of Nuclear Medicine November 2024, jnumed.124.268451; DOI: https://doi.org/10.2967/jnumed.124.268451 ...

PET-Based TheraP Eligibility and Outcomes of VISION-Eligible Patients with Metastatic Castration-Resistant Prostate Cancer Who Received 177 Lu-PSMA-617: Importance of 18 F-FDG–Avid Discordant Findings ...

Journal of Nuclear Medicine November 2024, jnumed.124.268167; DOI: https://doi.org/10.2967/jnumed.124.268167 ...

Journal of Nuclear Medicine November 2024, jnumed.124.267963; DOI: https://doi.org/10.2967/jnumed.124.267963 The integration of PET/CT systems, which was initially ...

Journal of Nuclear Medicine March 2006, 47 (3) 554-555; It might therefore be useful if the reading of both planar and tomographic (SPECT) scintimammography studies incorporated not only the typically ...

Journal of Nuclear Medicine October 2024, jnumed.124.268386; DOI: https://doi.org/10.2967/jnumed.124.268386 ...

S.J. McPhee, M.A. Papadakis, and L.M. Tierney, Jr., eds. New York, NY: McGraw Hill Medical, 2008, 1,673 pages, $69.95 Medicine is an ever-changing field, and changes in patient treatment are required ...